RESOURCES

RxFiber, LLC today announced that its high tenacity, next generation biomaterial for implantable medical devices, RxFibron HT (US Pat. 10,835,645), has been selected as a Golden Mousetrap Winner in the Materials and Assembly category. The Awards celebrate the companies, products, and people who are energizing North American design, engineering, and manufacturing. During a live ceremony, RxFiber’s President, Robert Torgerson, was presented the 2013 Golden Mousetrap Award on February 11, 2014. Continue reading...

The next generation in medical-grade fibers, RxFibron HT (US Pat. 10,835,645) is the first medical-grade PET to exhibit high-tenacity properties without compromising strength for developing low-profile devices. Continue reading...

In this feature, Robert Torgerson draws from his experience working as a senior engineer in the medical device industry and more recently, as the president of medical-grade fiber maker RxFiber, to offer advice on using biomaterials in ground-breaking medical device projects. Continue reading...

The use of foreign materials in the human body has an impressively long history. In approximately 600 A.D, the Mayans used mother of pearl to fashion dental implants that apparently integrated with bone. An iron dental implant dating back to 200 A.D. has been found in Europe. The use of sutures has an even longer history, stretching back some 32,000 years. Fast forwarding through the centuries, elephant ivory was used to fashion the first documented hip implant in 1891. Most biomaterials used over the course of history were intended to be biopassive—simply tolerated by the body. This is beginning to change, however, as there is increasing demand to create biomaterials that support the field of regenerative medicine. In the meantime, inert biomaterials are also continuing to evolve. Continue reading...

The use of industrial-grade yarn, which is used for applications such as seat-belts and t-shirts, has a long history in the medical device space. The use of such material for medical device applications, however, is becoming obsolete owing to increasing oversight from the FDA and other regulatory bodies. Continue reading...